Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Asset-Level IP Valuation: Keytruda, Eliquis, and Ozempic Mercks Keytruda (pembrolizumab) generates over $25 billion in annual revenue and is protected by a portfolio of patents covering the PD-1 antibody sequence, formulation, and dosing regimen
Participants will learn how to incorporate anti-obesity medications (AOMs) into treatment plans, how to assess and document a patients medication and supplement history, and how to tailor interventions for specific populations affected by obesity
For 8-12mg maintenance: 30mg vial + 1.5mL water = 20mg/mL
Parks, Mara Martnez-Gmez, M Serra Cusid, Neda Akhlaghi, Sergio Muoz-Martnez, Alba Jimnez-Masip, Juan M
US$ 25.32
US$ 27.67
US$ 25.30
US$ 23.78
US$ 25.16
US$ 27.03
US$ 22.24
